Bancroft Robert E. 4
4 · AEON Biopharma, Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
Bancroft Robert E.
DirectorPRESIDENT & CEO
Transactions
- Award
Stock Option
2025-04-29+59,034→ 59,034 totalExercise: $0.41Exp: 2035-04-29→ Class A Common Stock (59,034 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on each anniversary measured from April 29, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.